ArticleTranslational cancer research2026
Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis.
Lei Xiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.